Matinas BioPharma Holdings (MTNB) EBITDA Margin (2015 - 2023)
Matinas BioPharma Holdings (MTNB) posted EBITDA Margin of -2133.30% for FY2023, down 1372.54 percentage points from -760.76% in FY2022.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) EBITDA Margin (2015 - 2023) Analysis & Trends
Since FY2015, Matinas BioPharma Holdings has reported EBITDA Margin for 8 years.
- Annual EBITDA Margin shows a five-year change of +9915.33 percentage points (FY2018 to FY2023).
- Annual EBITDA Margin has run from a low of -74215.15% in FY2021 to a high of -760.76% in FY2022 over five years.
- Business Quant data shows MTNB's EBITDA Margin at -760.76% in FY2022 (+73454.39 pp), -74215.15% in FY2021 (-59072.70 pp), -15142.45% in FY2020 (+5695.60 pp) and -20838.05% in FY2019 (-8789.42 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -501.19% |
| Dec 31, 2022 | -506.77% |
| Sep 30, 2022 | -505.46% |
| Jun 30, 2022 | -549.29% |
| Mar 31, 2021 | -18,883.57% |
| Dec 31, 2020 | -10,289.72% |
| Sep 30, 2020 | -5,787.98% |
| Jun 30, 2019 | -4,978.86% |
| Jun 30, 2018 | -3,732.19% |
| Mar 31, 2018 | -13,607.28% |
| Dec 31, 2017 | -10,212.90% |
| Sep 30, 2017 | -7,519.86% |
| Jun 30, 2017 | -8,828.00% |
| Mar 31, 2017 | -29,896.71% |
| Sep 30, 2015 | -3,586.31% |
| Jun 30, 2015 | -3,106.58% |
| Mar 31, 2015 | -4,437.79% |
API Access
Matinas BioPharma Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();